Eli Lilly And Company (LLY) closed at $1411.95 on November 9, 2026, up 4.3% from the previous close, on volume of 3,001,769 shares (30-day average 2,602,457).
Data as of November 9, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Put Butterfly | 19-Mar-27800 : 1000[2x] : 1200 P | 3,216 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Hims & Hers (HIMS) Needs Better Profits to Justify Its Price
TipRanks (Tue, 10-Nov 10:07 AM ET)
Life doesn't slow down, and Foundayo (orforglipron) patient Leanne Morgan is done waiting
PRNewswire (Tue, 10-Nov 8:00 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Voyager Therapeutics (VYGR)
TipRanks (Tue, 10-Nov 2:50 AM ET)
Eli Lilly, Novo weight-loss drugs to get rare vision loss warning
Seeking Alpha News (Mon, 9-Nov 3:28 PM ET)
Eli Lilly, Novo weight-loss drugs to get rare eye loss warning
Seeking Alpha News (Mon, 9-Nov 3:28 PM ET)
Eli Lilly’s (LLY) Obesity Pill Found to Help with Sleep Apnea
TipRanks (Mon, 9-Nov 1:18 PM ET)
Eli Lilly releases Foundayo sleep apnea data
Seeking Alpha News (Mon, 9-Nov 11:39 AM ET)
Eli Lilly Stock (LLY) Gains After Canada Recommends Public Reimbursement of Its Alzheimer’s Drug
TipRanks (Mon, 9-Nov 10:17 AM ET)
Eli Lilly Stock (LLY) Rises After Canada Approves Public Reimbursement of Its Alzheimer’s Drug
TipRanks (Mon, 9-Nov 10:17 AM ET)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly And Company trades on the NYSE stock market under the symbol LLY.
As of November 10, 2026, LLY stock price climbed to $1,416.60 with 447,262 million shares trading.
LLY has a beta of 0.01, meaning it tends to be less sensitive to market movements. LLY has a correlation of 0.00 to the broad based SPY ETF.
LLY has a market cap of $1.26 trillion. This is considered a Mega Cap stock.
Last quarter Eli Lilly And Company reported $24 billion in Revenue and $7.48 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $1.12.
In the last 3 years, LLY traded as high as $1,453.00 and as low as $561.65.
The top ETF exchange traded funds that LLY belongs to (by Net Assets): VTI, VOO, IVV, SPY, VUG.
LLY has outperformed the market in the last year with a price return of +54.0% while the SPY ETF gained +12.8%. LLY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.6% and +10.7%, respectively, while the SPY returned -2.9% and -2.1%, respectively.
LLY support price is $1,379.16 and resistance is $1,444.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LLY shares will trade within this expected range on the day.
